Major CLL trial tests three drug combos to find best control strategy
Disease control
Ongoing
This study compares three treatment approaches for people with previously untreated chronic lymphocytic leukemia (CLL): one drug taken continuously (ibrutinib), two drugs given for a fixed time (venetoclax plus obinutuzumab), and a combination of two drugs for a fixed time (ibrut…
Phase: PHASE3 • Sponsor: German CLL Study Group • Aim: Disease control
Last updated May 04, 2026 16:32 UTC